RT Journal Article
SR Electronic
T1 751 Monotherapy results from an ongoing phase 1a dose escalation study of NDI-101150, a highly selective oral hematopoietic progenitor kinase 1 (HPK1) inhibitor
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A847
OP A847
DO 10.1136/jitc-2023-SITC2023.0751
VO 11
IS Suppl 1
A1 Sommerhalder, David
A1 Noel, Marcus
A1 Boiko, Scott
A1 Daigle, Scott
A1 Zhang, Xinyan
A1 Fraser, Patricia
A1 Hoerres, Amanda
A1 Rana, Nawaid
A1 Gangolli, Esha A
A1 Basile, Frank G
A1 Srivastava, Bhaskar
A1 Sharma, Sunil
A1 Balaraman, Rama
A1 Gutierrez, Martin
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A847.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.